mRNA-1273 and Ad26.COV2.S vaccines protect against B.1.621 variant of SARS-CoV-2

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://immport.org/shared/study/SDY2860

下载链接

链接失效反馈

官方服务：

资源简介：

Here, we evaluated in mice and hamsters the efficacy of a pre-clinical version of the Moderna mRNA vaccine (mRNA-1273) and the Johnson and Johnson recombinant adenoviral-vectored vaccine (Ad26.COV2.S) against the B.1.621 (Mu) variant of SARS-CoV-2, which contains spike mutations T95I, Y144S, Y145N, R346K, E484K, N501Y, D614G, P681H, and D950N.

创建时间：

2025-10-30